The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones

NCT ID: NCT02589028

Last Updated: 2017-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to explore premeal protein-enriched bar effect in postprandial glucose levels and concentration of plasma incretin hormones \[glucagon-like peptide 1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP)\] in healthy subjects and those with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fifteen healthy subjects and fifteen subjects with type 2 diabetes treated by diet and/or metformin, SU, DPP4 inhibitors will be recruited. Every subject will studied on 2 separate days in random order with 1-2 week intervals. These participants will consume protein enriched bar followed by a standardized high-glycemic-index breakfast in a hospital setting or breakfast followed protein enriched bar in a cross-over fashion. Blood sampling will be done at the moment of start of breakfast (0 min) and then 10, 20, 30, 60, 90, 120, 150, 180 min. Plasma glucose levels, total/active GLP-1, GIP, insulin, C-peptide, glucagon will be measured. Incremental area under the curve (iAUC) of glucose level and hormone from 0 min to 180 min will be calculated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

diabetes mellitus incretin hormone glucose level GLP-1 GIP premeal protein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

premeal protein bar first

intervention: premeal protein-enriched bar intake

* protein enriched bar(total serving: 30g, 43.28% carbohydrate; 1.29% fat; 40.39% protein; 42.63% fiber) will be given 30 minutes before breakfast
* protein enriched bar is provided with 150 ml of water
* amount of protein bar : 30g
* breakfast : plain bagel, cream cheese, strawberry jam, orange juice 210ml

Group Type EXPERIMENTAL

premeal protein-enriched bar intake

Intervention Type DIETARY_SUPPLEMENT

Premeal protein bar is provided 30 minutes before breakfast. Participants have to eat protein bar with in 5 minutes with 150ml of water.

breakfast first

intervention: breakfast follows by protein bar

* protein enriched bar is provided with 150 ml of water shortly after breakfast
* amount of protein bar : 30g
* breakfast : plain bagel, cream cheese, strawberry jam, orange juice 210ml

Group Type OTHER

breakfast follows by protein bar

Intervention Type OTHER

Participants have to eat provided breakfast within 30 minutes. It is recommended for participants to eat protein bar shortly after finishing breakfast within 5 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

premeal protein-enriched bar intake

Premeal protein bar is provided 30 minutes before breakfast. Participants have to eat protein bar with in 5 minutes with 150ml of water.

Intervention Type DIETARY_SUPPLEMENT

breakfast follows by protein bar

Participants have to eat provided breakfast within 30 minutes. It is recommended for participants to eat protein bar shortly after finishing breakfast within 5 minutes.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

premeal protein bar

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI 18.5\~35 kg/m2
* Healthy volunteer:

* never diagnosed by diabetes and
* fasting plasma glucose \<=100mg/dl and HbA1c \<6.0%
* participants with diabetes

* diagnosed by diabetes
* if treated by diet, HbA1c 6.0\~9.0%
* if treated by metformin or SU, HbA1c 6.0\~10.0%
* if treated by DPP4 inhibitor HbA1c 6.0\~9.0%

Exclusion Criteria

* Those who diagnosed by Type 1 diabetes
* History of DKA
* History of insulin therapy
* Allergy to wheat, flour, nuts, milk
* Pregnancy/lactation
* AST or ALT \>2.5 times of upper normal reference range
* eGFR \<30 mL/min/1.73m2
* Hb \<10g/dl
* History of GI surgery (except hemorrhoidectomy, appendectomy)
Minimum Eligible Age

19 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Young Min Cho, MD, PHD

Role: STUDY_CHAIR

Associate Professor Division of Endocrinology and Metabolism Department of Internal Medicine Seoul National University College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-1504-103-666

Identifier Type: -

Identifier Source: org_study_id